Lawyer profile
Kevin Zhang
Latham & Watkins LLP
- Firm
- Latham & Watkins LLP
- Practice
- capital markets, converts matters, corporate
- Office
- New York
- Active in the record
- 2022 to 2024
Deal experience
Deals
7 announced deals in the record Latham & Watkins Advises Arcus Biosciences in US$250 Million Growth Facility 31 Aug 2024
Latham & Watkins Advises on ANI Pharmaceuticals’ Upsized US$316.25 Million Convertible Senior Notes Offering 16 Aug 2024
Latham & Watkins Advises Verona Pharma in US$650 Million Strategic Financing, One of the Largest Life Sciences Financings of 2024 16 May 2024
Latham & Watkins Represents Vertex, Inc. in Financing for Acquisition of E-Invoicing Leader Pagero 16 Dec 2023
Latham & Watkins Advises on Freshpet, Inc.’s US$350 Million Convertible Senior Notes Offering 17 Mar 2023
Latham & Watkins Represents Wolfspeed in Upsized US$1,525 Million Convertible Senior Notes Offering 18 Nov 2022
Latham & Watkins Advises Marti in its Merger with Galata Acquisition Corp. 2 Aug 2022
Deal alerts PRO
Get an email when Kevin Zhang is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile